CD68 and neoplasm: Rubenstein et al. demonstrated IL-10 overexpression in lymphoma cells by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry analysis, while Sasayama confirmed the expression of IL-10 in CD68+ and CD163+ tumor-associated macrophages by double immunostaining analysis [11, 20].